Enterome vs Genexine

Enterome vs Genexine, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Enterome is on 60/100 and Genexine on 47/100.

Enterome logo
EnteromeClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Try Enterome
GenexineSouth Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.
Try Genexine

Where each one leads

Enterome

  • our overall score: 60/100 against 47/100
  • domain rating: 46/100 against 32/100

Genexine

  • agent readiness: 28/100 against 21/100
  • funding raised: $297M against $124M

At a glance

MeasureEnteromeGenexine
What it isClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.South Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.
CategoryBiotechnology, Drug Discovery, Oncology, ImmunotherapyBiotechnology, HealthTech, Drug Discovery, Immunotherapy
Sells toBusiness modelB2BB2B
OfferingSoftware | hardware | services | marketplace | platformSoftware | hardware | services | marketplace | platform
Founded20121999
HeadquartersParis, FranceSeoul, South Korea
StatusActiveActive

Size, funding and growth

MeasureEnteromeGenexine
Employees33Not published
Total funding$124M$297M
Latest roundLater Stage VCFunding
LinkedIn followers16,846Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureEnteromeGenexine
StartupHub scoreOur 0-100 rating60/10047/100
Traction55/10040/100
Team70/10050/100
Search visibility34/1005/100
Quality68/10058/100
Agent readinessHow well an AI agent can read and act on the siteF (21/100)F (28/100)
Domain ratingLink authority, 0-10046/10032/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureEnteromeGenexine
HostingSelf ManagedNot detected
CMSWordPressNot detected
FrameworksBootstrapNot detected
AnalyticsGoogle Analytics 4, SegmentNot detected

Enterome vs Genexine: common questions

Which is better, Enterome or Genexine?

On our 0-100 score Enterome rates higher (60/100 against 47/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.

How do Enterome and Genexine compare on the numbers?

Enterome leads on our overall score (60/100 against 47/100), domain rating (46/100 against 32/100). Genexine leads on agent readiness (28/100 against 21/100), funding raised ($297M against $124M).

Read the full Enterome review and pricing or the Genexine review and pricing. You can also browse other Enterome alternatives we track.